Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Primer: Lion Rock Group (1127 HK) – Nov 2025 and more

In today’s briefing:

  • Primer: Lion Rock Group (1127 HK) – Nov 2025
  • Omada Health (OMDA.US): Robust 3Q Undermined by Sentiment, Long-Term Bullish Thesis Intact
  • NEC (6701 JP): Tie-Up with Siemens Adds to Growth Potential
  • China Healthcare Weekly (Nov.9)-Medical Insurance “Warning Lines”, NewCo Model, BeiGene 25Q3 Results
  • Mitsui & Co. (8031 JP): Bullish View Reinforced — Copper & LNG Re-Rate Now Structural
  • Primer: Macnica Holdings Inc (3132 JP) – Nov 2025
  • Primer: Serve Robotics (1234 US) – Nov 2025
  • Taiwan Dual-Listings Monitor: TSMC Premium Eases Down; UMC & CHT Opportunity Levels
  • Maersk Q325 Results: Core Ocean Down 55% Y/Y | Downbeat Guidance from Management | Q425 Losses?
  • Primer: Bitfarms (BITF US) – Nov 2025


Primer: Lion Rock Group (1127 HK) – Nov 2025

By αSK

  • Lion Rock Group is a global printing services provider with a strong foothold in the international book publishing market, demonstrating consistent revenue growth and robust cash flow generation.
  • The company faces headwinds from the secular decline of traditional print media but is actively pursuing growth through strategic acquisitions and operational diversification, particularly in Australia and Southeast Asia.
  • Valuation appears attractive, with low earnings multiples and a high dividend yield, suggesting a value proposition for investors, balanced against the inherent risks of the evolving printing industry.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Omada Health (OMDA.US): Robust 3Q Undermined by Sentiment, Long-Term Bullish Thesis Intact

By Andrei Zakharov

  • Omada Health reported stronger than expected 3Q25 revenue of ~$68M (consensus: $61.2M) and management provided guidance for 2025 revenue of $251.5M-$254.5M, +49% y/y at midpoint.  
  • The chronic disease management company introduced Meal Map, a new AI-powered nutrition tool integrated within the Omada Health’s cardiometabolic programs.
  • I’m updating OMDA model estimates in my insight to reflect the company’s 3Q25 results, management guidance, and trends in the digital therapeutics space.

NEC (6701 JP): Tie-Up with Siemens Adds to Growth Potential

By Scott Foster

  • NEC and Siemens plan to develop an automated robot teaching system for faster set-up and more efficient operation of production lines incorporating multiple robots.
  • NEC’s FY Mar-26 guidance raised on strong 1H results. BluStellar, which includes digital twins for robot teaching, grew faster than expected.  
  • Aerospace/Defense led sales growth and followed BluStellar in operating profit. Improving product mix and rising Japanese defense budget point to growing long-term potential.

China Healthcare Weekly (Nov.9)-Medical Insurance “Warning Lines”, NewCo Model, BeiGene 25Q3 Results

By Xinyao (Criss) Wang

  • The medical insurance fund has crossed certain “warning lines”. Therefore, it is inevitable that the measures to control costs at the expenditure end will be further tightened.
  • We are actually not optimistic about the NewCo model, because domestic pharmaceutical companies may not necessarily be able to share much of Newco’s future development achievements in the end.
  • BeiGene’s 25Q3 results beat expectations. However, there’s no next blockbuster that can drive BeiGene to a big step forward, this is why the market is reluctant to offer higher valuation.

Mitsui & Co. (8031 JP): Bullish View Reinforced — Copper & LNG Re-Rate Now Structural

By Rahul Jain

  • 1H FY26 results resilient: LNG and FX offset metals softness; FY26 NI raised 6% to ¥820 bn, ROE ~13%.
  • Valuation gap to Itochu closed; Mitsui now trades ~1.4× P/B with superior copper and LNG leverage.
  • Sustained buybacks (~5% p.a.) and ≥10% Berkshire anchor ensure 6–9% TSR CAGR, with 10%+ if copper >US$10k/t.

Primer: Macnica Holdings Inc (3132 JP) – Nov 2025

By αSK

  • Macnica is a leading Japanese technology distributor specializing in semiconductors and network equipment, well-positioned to capitalize on long-term growth in AI, IoT, and automotive sectors.
  • The company is strategically shifting towards a higher-margin ‘Services & Solutions’ model, expanding beyond traditional distribution to include proprietary products and cybersecurity services.
  • While facing near-term headwinds from semiconductor market cyclicality and margin pressure, Macnica maintains a strong balance sheet, attractive dividend yield, and a valuation that appears reasonable compared to global peers.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Serve Robotics (1234 US) – Nov 2025

By αSK

  • Serve Robotics is a key player in the nascent autonomous sidewalk delivery market, with a strategic focus on last-mile food and grocery delivery.
  • The company’s growth is underpinned by significant partnerships with major food delivery platforms, Uber Eats and DoorDash, providing immediate access to a large volume of orders.
  • While experiencing rapid revenue growth, the company remains unprofitable with significant cash burn, highlighting the high-risk, high-reward nature of this emerging industry. The path to profitability hinges on successful fleet expansion, operational efficiency, and navigating regulatory landscapes.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Taiwan Dual-Listings Monitor: TSMC Premium Eases Down; UMC & CHT Opportunity Levels

By Vincent Fernando, CFA

  • TSMC: +21.8% Premium; Wait for Lower Premium Before Fresh Long
  • UMC: +2.2% Premium; Good Level to Short the ADR Premium
  • CHT: -2.0% Discount; Near Level to Go Long the ADR Spread

Maersk Q325 Results: Core Ocean Down 55% Y/Y | Downbeat Guidance from Management | Q425 Losses?

By Daniel Hellberg

  • Core “Ocean” EBITDA fell by 55% Y/Y in Q325 due to lower average freight rates
  • Maersk lifted lower end of guidance range, but offered downbeat tone on Q4, 2026
  • Shares fell by 5% in response to Thursday’s report; we remain negative on sector

Primer: Bitfarms (BITF US) – Nov 2025

By αSK

  • Bitfarms is a vertically integrated Bitcoin mining company aggressively expanding its operational footprint in North America and diversifying into High-Performance Computing (HPC) and AI infrastructure to create new, stable revenue streams.
  • The company’s strategy hinges on leveraging low-cost, primarily renewable energy sources to maintain competitiveness in a post-halving environment, where operational efficiency is paramount for profitability.
  • Significant financial risks exist, including a history of net losses, high stock volatility, and execution risk associated with its capital-intensive pivot to the AI/HPC sector, alongside its inherent exposure to the volatile price of Bitcoin.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars